Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 47, 2012 - Issue 1
Submit an article Journal homepage
850
Views
63
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor

Constantin S JianuDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayCorrespondence[email protected]
,
Ove J LangeDepartment of Gastroenterology, Molde Hospital, Molde, Norway
,
Trond VisetDepartments of Pathology and Medical Genetics, St. Olavs Hospital, Trondheim, Norway
,
Gunnar QvigstadDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Tom C MartinsenDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Reidun FougnerDepartments of Radiology, St. Olavs Hospital, Trondheim, Norway
,
Per M KlevelandDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Reidar FossmarkDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Øyvind HausoDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
&
Helge L WaldumDepartments of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
 show all
Pages 64-67 | Received 26 Apr 2011, Accepted 30 Aug 2011, Published online: 16 Nov 2011

Citations (63)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Helge L. Waldum. (2020) Clinical consequences of controversies in gastric physiology. Scandinavian Journal of Gastroenterology 55:6, pages 752-758.
Read now
Jens F. Rehfeld, Filip K. Knop & Meena Asmar. (2019) Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?. Scandinavian Journal of Gastroenterology 54:12, pages 1448-1451.
Read now
Helge L. Waldum, Øyvind Hauso, Eiliv Brenna, Gunnar Qvigstad & Reidar Fossmark. (2016) Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?. Scandinavian Journal of Gastroenterology 51:7, pages 767-773.
Read now
Yanna Ko, James Tang, Santosh Sanagapalli, Bong Sik Matthew Kim & Rupert W Leong. (2016) Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms. Expert Opinion on Drug Safety 15:1, pages 53-63.
Read now
Federica Cavalcoli, Alessandra Zilli, Dario Conte, Clorinda Ciafardini & Sara Massironi. (2015) Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?. Scandinavian Journal of Gastroenterology 50:11, pages 1397-1403.
Read now
Louis de Mestier, Marie-Danièle Diebold, Franck Devulder, Remi Picot & Guillaume Cadiot. (2015) Gastric carcinoids escaping the currently available classification. Scandinavian Journal of Gastroenterology 50:5, pages 621-622.
Read now
Malcolm Boyce & Liv Thomsen. (2015) Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scandinavian Journal of Gastroenterology 50:5, pages 550-559.
Read now
Edith Lahner, Emanuela Pilozzi, Gianluca Esposito, Gloria Galli & Bruno Annibale. (2014) Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge. Scandinavian Journal of Gastroenterology 49:4, pages 506-510.
Read now

Articles from other publishers (55)

Soichiro Nagao, Yohei Yabuuchi, Kosuke Tanaka, Yoshiki Morihisa, Takuya Kobayashi, Shinsuke Akiyama, Gensho Tanke, Masaya Wada, Shuko Morita, Satoko Inoue, Hiroshi Tei, Daisuke Yamashita & Tetsuro Inokuma. (2024) Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker. Internal Medicine.
Crossref
Helge Waldum & Patricia Mjønes. (2023) The central role of gastrin in gastric cancer. Frontiers in Oncology 13.
Crossref
Hironori Tanaka, Toshihisa Takeuchi, Shinya Nishida, Hitosi Hongo, Michiaki Takii, Takeshi Higashino, Makoto Sanomura, Hirota Miyazaki, Masahiro Hoshimoto, Tsuguhiro Kimura, Masahiro Sakaguchi, Takashi Abe, Akitoshi Hakoda, Noriaki Sugawara, Taro Iwatsubo, Shinpei Kawaguchi, Kazuhiro Ota, Yuichi Kojima & Kazuhide Higuchi. (2023) Examination on Factors Affecting Symptom Change after Drug Withdrawal in Patients with Mild Erosive Gastroesophageal Reflux Disease Undergoing Symptom-Controlled Maintenance Therapy with Acid-Secretion Inhibition Drugs. Digestion 104:4, pages 270-282.
Crossref
Ion G. Motofei. (2022) Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Seminars in Cancer Biology 86, pages 600-615.
Crossref
Selma Şengiz Erhan, Aytül Buğra, Sevinç Hallaç Keser & Ali Alemdar. (2022) Metastatic multiple gastric neuroendocrine tumors with a long history of proton pump inhibitor use: A case report. Journal of Surgery and Medicine 6:10, pages 882-886.
Crossref
Koichiro Kawaguchi, Kazuo Yashima, Yuichiro Ikebuchi, Akira Yoshida, Satoshi Kuwamoto & Hajime Isomoto. (2022) The First Case of Gastric Neuroendocrine Tumors Induced by a Proton Pump Inhibitor in von Hippel-Lindau Disease. Internal Medicine 61:17, pages 2587-2592.
Crossref
Masaya Iwamuro, Haruo Urata, Takehiro Tanaka & Hiroyuki Okada. (2022) Application of electron microscopy in gastroenterology. World Journal of Gastrointestinal Pathophysiology 13:2, pages 41-49.
Crossref
Rehan Rais, Nikolaos A. Trikalinos, Jingxia Liu & Deyali Chatterjee. (2021) Enterochromaffin-like Cell Hyperplasia–Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use. Archives of Pathology & Laboratory Medicine 146:3, pages 366-371.
Crossref
Takahiro Suzuki, Tomohiro Higuchi, Takuma Kagami, Takahiro Uotani, Mihoko Yamade, Shinya Tani, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Ken Sugimoto, Hiroaki Miyajima & Takahisa Furuta. (2021) Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia. European Journal of Clinical Pharmacology 77:7, pages 971-978.
Crossref
Helge Waldum. (2021) Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer. Cancers 13:13, pages 3159.
Crossref
Helge Waldum & Reidar Fossmark. (2021) Gastritis, Gastric Polyps and Gastric Cancer. International Journal of Molecular Sciences 22:12, pages 6548.
Crossref
Helge Waldum & Patricia Mjønes. (2020) Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers 12:11, pages 3477.
Crossref
Atsushi Tatsuguchi, Shintaro Hoshino, Noriyuki Kawami, Katya Gudis, Tsutomu Nomura, Akira Shimizu & Katsuhiko Iwakiri. (2020) Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa. Pathology - Research and Practice 216:10, pages 153113.
Crossref
Murat İSPİROĞLU, Kadir GİŞİ & Bülent KANTARÇEKEN. (2020) Proton Pompa İnhibitörlerinin Uzun Dönem Kullanımındaki Etkileri. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi.
Crossref
Toshihisa Takeuchi, Takahisa Furuta, Yasuhiro Fujiwara, Mitsushige Sugimoto, Kunio Kasugai, Motoyasu Kusano, Hiroyuki Okada, Takahiro Suzuki, Tomohiro Higuchi, Takuma Kagami, Takahiro Uotani, Mihoko Yamade, Akinari Sawada, Fumio Tanaka, Satoshi Harada, Kazuhiro Ota, Yuichi Kojima, Masaki Murata, Yasuhiro Tamura, Yasushi Funaki, Osamu Kawamura, Yuki Okamoto, Kazuma Fujimoto & Kazuhide Higuchi. (2020) Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study). Alimentary Pharmacology & Therapeutics 51:5, pages 534-543.
Crossref
Denis M. McCarthy. (2020) Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?. International Journal of Molecular Sciences 21:2, pages 662.
Crossref
Helgadottir & Bjornsson. (2019) Problems Associated with Deprescribing of Proton Pump Inhibitors. International Journal of Molecular Sciences 20:21, pages 5469.
Crossref
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Lama Soubra & Mohamed Issa. (2019) Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks. International Journal of Pharmacy Practice 27:4, pages 386-392.
Crossref
Shuichi Miyamoto, Momoko Tsuda, Mototsugu Kato, Katsuhiro Mabe, Shuichi Muto, Shoko Ono, Yuichi Shimizu & Naoya Sakamoto. (2019) Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test. Journal of Clinical Biochemistry and Nutrition 64:2, pages 174-179.
Crossref
R. Soto-Solís, A.F. Romano-Munive, K. Santana de Anda & R. Barreto-Zuñiga. (2019) Factors related to gastric neuroendocrine tumors. Revista de Gastroenterología de México (English Edition) 84:1, pages 52-56.
Crossref
R. Soto-Solís, A.F. Romano-Munive, K. Santana de Anda & R. Barreto-Zuñiga. (2019) Factores relacionados a tumores neuroendocrinos gástricos. Revista de Gastroenterología de México 84:1, pages 52-56.
Crossref
En-Su Chang, Diego S.-C. Lin, Ming-Chih Hou & Chih-Yen Chen. (2018) Incidental endoscopic findings of a rare gastric neuroendocrine carcinoma concurrent with an uncommon primary duodenal adenocarcinoma: A case report. Advances in Digestive Medicine 5:3, pages 106-109.
Crossref
Yuichi Kojima, Toshihisa Takeuchi, Makoto Sanomura, Ken Higashino, Keishi Kojima, Kenji Fukumoto, Kou Takata, Hiroki Sakamoto, Masahiro Sakaguchi, Kazunari Tominaga & Kazuhide Higuchi. (2018) Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study. Digestion 97:1, pages 70-75.
Crossref
Takahiro Suzuki, Takuma Kagami, Takahiro Uotani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Ken Sugimoto, Hiroaki Miyajima & Takahisa Furuta. (2017) Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin. European Journal of Clinical Pharmacology 74:1, pages 45-52.
Crossref
Robert B. Yates, Carlos A. Pellegrini & Brant K. Oelschlager. 2018. Lung Transplantation. Lung Transplantation 279 299 .
Daniel H. Dunn, Eric M. Johnson, Tor C. Aasheim & Nilanjana Banerji. 2018. The SAGES Atlas of Robotic Surgery. The SAGES Atlas of Robotic Surgery 379 395 .
Zhen-Ning Lu, Bing Tian & Xiu-Li Guo. (2017) Repositioning of proton pump inhibitors in cancer therapy. Cancer Chemotherapy and Pharmacology 80:5, pages 925-937.
Crossref
QU Baoge. (2017) Influence of Long-Term Use of Proton Pump Inhibitors on Esophageal and Gastrointestinal Precancerous Lesions or Carcinoma. Archives of Clinical Gastroenterology, pages 029-032.
Crossref
Hajime Anjiki, Ken-ichi Mukaisho, Yu Kadomoto, Hisakazu Doi, Kunio Yoshikawa, Takahisa Nakayama, Diem Thi-Ngoc Vo, Takanori Hattori & Hiroyuki Sugihara. (2017) Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy. Clinical Journal of Gastroenterology 10:2, pages 128-136.
Crossref
Yan-Jiun Huang, Alexander TH Wu, Hung-Yi Chiou, Ming-Tsang Chuang, Tzu-Ching Meng, Li-Nien Chien & Yun Yen. (2016) Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study. Oncotarget 8:4, pages 6642-6651.
Crossref
Helge L. Waldum, Liv Sagatun & Patricia Mjønes. (2017) Gastrin and Gastric Cancer. Frontiers in Endocrinology 8.
Crossref
Malcolm Boyce, Katie A Lloyd & D Mark Pritchard. (2016) Potential clinical indications for a CCK2 receptor antagonist. Current Opinion in Pharmacology 31, pages 68-75.
Crossref
Vincenzo Savarino, Pietro Dulbecco & Edoardo Savarino. (2016) Are proton pump inhibitors really so dangerous?. Digestive and Liver Disease 48:8, pages 851-859.
Crossref
Reidar Fossmark, Oriol Calvete, Patricia Mjønes, Javier Benitez & Helge L. Waldum. (2016) ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H + K + ATPase alpha subunit . APMIS 124:7, pages 561-566.
Crossref
T. Kagami, S. Sahara, H. Ichikawa, T. Uotani, M. Yamade, M. Sugimoto, Y. Hamaya, M. Iwaizumi, S. Osawa, K. Sugimoto, H. Miyajima & T. Furuta. (2016) Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype . Alimentary Pharmacology & Therapeutics 43:10, pages 1048-1059.
Crossref
Bruce Mahoney & Jennifer Scheler. (2016) Somatostatin Receptor Scintigraphy of Neuroendocrine Tumors of the Abdomen and Pelvis. Seminars in Roentgenology 51:2, pages 112-122.
Crossref
Li‐Nien Chien, Yan‐Jiun Huang, Yu‐Hsuan Joni Shao, Chen‐Jung Chang, Ming‐Tsang Chuang, Hung‐Yi Chiou & Yun Yen. (2015) Proton pump inhibitors and risk of periampullary cancers—A nested case–control study. International Journal of Cancer 138:6, pages 1401-1409.
Crossref
Nina Nandy, Joshua A. Hanson, Robert G. Strickland & Denis M. McCarthy. (2015) Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature. Digestive Diseases and Sciences 61:3, pages 708-712.
Crossref
Evita Henderson-Jackson, Ujalla Sheikh, Jalil Muhammad, Domenico Coppola & Aejaz Nasir. 2016. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances 217 244 .
Maria Meli, Maria Pia Raffa, Renato Malta, Ilaria Morreale, Luigi Aprea & Natale D’Alessandro. (2015) The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients. International Journal of Clinical Pharmacy 37:6, pages 1152-1161.
Crossref
L. Lundell, M. Vieth, F. Gibson, P. Nagy & P. J. Kahrilas. (2015) Systematic review: the effects of long‐term proton pump inhibitor use on serum gastrin levels and gastric histology. Alimentary Pharmacology & Therapeutics 42:6, pages 649-663.
Crossref
Andrea GrinCatherine J. Streutker. (2015) Neuroendocrine Tumors of the Luminal Gastrointestinal Tract. Archives of Pathology & Laboratory Medicine 139:6, pages 750-756.
Crossref
Ece Esin, Tugba Akin Telli & Suayib Yalcin. 2015. Neuroendocrine Tumours. Neuroendocrine Tumours 165 178 .
R. Basuroy, R. Srirajaskanthan, A. Prachalias, A. Quaglia & J. K. Ramage. (2014) Review article: the investigation and management of gastric neuroendocrine tumours. Alimentary Pharmacology & Therapeutics 39:10, pages 1071-1084.
Crossref
Marco Volante, Nadia Birocco, Gaia Gatti, Eleonora Duregon, Katia Lorizzo, Nicola Fazio, Giorgio V. Scagliotti & Mauro Papotti. (2014) Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. Human Pathology 45:4, pages 665-673.
Crossref
H. L. Waldum, Ø. Hauso & R. Fossmark. (2014) The regulation of gastric acid secretion - clinical perspectives. Acta Physiologica 210:2, pages 239-256.
Crossref
Corrado Blandizzi & Carmelo Scarpignato. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 633 658 .
Wensheng Liu, Susan S. Baker, Jonathan Trinidad, Alma L. Burlingame, Robert D. Baker, John G. Forte, Lauren P. Virtuoso, Nejat K. Egilmez & Lixin Zhu. (2013) Inhibition of lysosomal enzyme activities by proton pump inhibitors. Journal of Gastroenterology 48:12, pages 1343-1352.
Crossref
Yasser H. Shaib, Massimo Rugge, David Y. Graham & Robert M. Genta. (2013) Management of Gastric Polyps: An Endoscopy-Based Approach. Clinical Gastroenterology and Hepatology 11:11, pages 1374-1384.
Crossref
Amber N. Cockburn, Christopher J. Morgan & Robert M. Genta. (2013) Neuroendocrine Proliferations of the Stomach. Advances in Anatomic Pathology 20:3, pages 148-157.
Crossref
C. S. Jianu, R. Fossmark, T. Viset, G. Qvigstad, Ø. Sørdal, R. Mårvik & H. L. Waldum. (2012) Gastric carcinoids after long‐term use of a proton pump inhibitor. Alimentary Pharmacology & Therapeutics 36:7, pages 644-649.
Crossref
Hala H. Mosli, Alan Dennis, Walter Kocha, Linda J. Asher & Stan H. M. Van Uum. (2012) Effect of Short-Term Proton Pump Inhibitor Treatment and Its Discontinuation on Chromogranin A in Healthy Subjects. The Journal of Clinical Endocrinology & Metabolism 97:9, pages E1731-E1735.
Crossref
J.-D. de Korwin. (2012) Pourquoi et comment arrêter un traitement prolongé par les inhibiteurs de la pompe à protons ?. La Revue de Médecine Interne 33:8, pages 417-420.
Crossref
Joel J. Heidelbaugh, Andrea H. Kim, Robert Chang & Paul C. Walker. (2012) Overutilization of proton-pump inhibitors: what the clinician needs to know. Therapeutic Advances in Gastroenterology 5:4, pages 219-232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.